| P2093 | author name string | Cleland JG | |
| | Clark AL | |
| | Witte KK | |
| P2860 | cites work | Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico | Q28143207 |
| | Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase | Q28284593 |
| | Aging decreases the capacity of human skin to produce vitamin D3 | Q28360343 |
| | Magnesium deficiency in adult rats promotes the induction of ventricular tachycardia by the administration of epinephrine | Q28376012 |
| | Antioxidant potentials of vitamin A and carotenoids and their relevance to heart disease | Q33602930 |
| | The antioxidant function of metallothionein in the heart | Q33796859 |
| | Catabolism in chronic heart failure | Q33896385 |
| | Low-dose alpha-tocopherol improves and high-dose alpha-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits. | Q34127841 |
| | Aspirin in the primary prevention of angina pectoris in a randomized trial of United States physicians | Q68621752 |
| | Selenium in cardiology and angiology | Q69137333 |
| | Edema of cardiac origin. Studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure | Q69664256 |
| | Serum magnesium levels in symptomatic atrial fibrillation and their relation to rhythm control by intravenous digoxin | Q69879771 |
| | The influence of smoking on vitamin C status in adults | Q69940981 |
| | Hypocalcemic Torsades de Pointes | Q69955588 |
| | Platelet function in type I diabetes: effects of supplementation with large doses of vitamin E | Q70046323 |
| | Clinical and prognostic significance of serum magnesium concentration in patients with severe chronic congestive heart failure: the PROMISE Study | Q70568678 |
| | Decreased ubiquinone levels in tissues of rats deficient in selenium | Q70575606 |
| | Furosemide-induced thiamine deficiency | Q70722116 |
| | The cooperative interaction between vitamin E and vitamin C in suppression of peroxidation of membrane phospholipids | Q70820414 |
| | Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women | Q71002942 |
| | Usefulness of antioxidant vitamins in suspected acute myocardial infarction (the Indian experiment of infarct survival-3) | Q71015631 |
| | Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS) | Q71060539 |
| | Energy expenditure and symptom severity in men with heart failure | Q71126005 |
| | Fat malabsorption in elderly patients with cardiac cachexia | Q71160571 |
| | Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: the Established Populations for Epidemiologic Studies of the Elderly | Q71224908 |
| | Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury | Q71282008 |
| | Evidence for altered structure and impaired mitochondrial electron transport function in selenium deficiency | Q71314933 |
| | Anti-ischaemic efficacy of L-propionylcarnitine--a promising novel metabolic approach to ischaemia? | Q71338688 |
| | Effects of vitamin E on endothelial function in men after myocardial infarction | Q71551154 |
| | Type II diabetes mellitus, congestive heart failure, and zinc metabolism | Q71611297 |
| | Additional antiischemic effects of long-term L-propionylcarnitine in anginal patients treated with conventional antianginal therapy | Q71637741 |
| | alpha-tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism | Q71785121 |
| | Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease | Q71807467 |
| | Effects of vitamin B12, folate, and vitamin B6 supplements in elderly people with normal serum vitamin concentrations | Q71852023 |
| | Effects of L-carnitine administration on left ventricular remodeling after acute anterior myocardial infarction: the L-Carnitine Ecocardiografia Digitalizzata Infarto Miocardico (CEDIM) Trial | Q71870053 |
| | Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine | Q34213851 |
| | Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans | Q34256239 |
| | Italian multicenter study on the safety and efficacy of coenzyme Q10 as adjunctive therapy in heart failure. CoQ10 Drug Surveillance Investigators | Q34310810 |
| | Effect of coenzyme Q10 therapy in patients with congestive heart failure: a long-term multicenter randomized study | Q34344695 |
| | Vitamin E consumption and the risk of coronary heart disease in men. | Q34363912 |
| | The epidemiology of heart failure | Q34417319 |
| | Wasting as independent risk factor for mortality in chronic heart failure | Q34421966 |
| | Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction | Q34429790 |
| | Clinical relevance of thiamine status amongst hospitalized elderly patients. | Q34756617 |
| | Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis | Q35571273 |
| | Lipid-lowering drugs and mitochondrial function: effects of HMG-CoA reductase inhibitors on serum ubiquinone and blood lactate/pyruvate ratio | Q36093796 |
| | Vitamin C deficiency and risk of myocardial infarction: prospective population study of men from eastern Finland | Q36243161 |
| | A randomised, double-blind, placebo-controlled trial of L-carnitine in suspected acute myocardial infarction | Q36680433 |
| | Statistical data support prediction of death within 6 months on low levels of coenzyme Q10 and other entities | Q36755952 |
| | Vitamin C and risk of death from stroke and coronary heart disease in cohort of elderly people | Q36903935 |
| | Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator | Q36994546 |
| | Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus | Q37350875 |
| | 1,25(OH)2 vitamin D3, and retinoic acid antagonize endothelin-stimulated hypertrophy of neonatal rat cardiac myocytes | Q37353500 |
| | Vascular incorporation of alpha-tocopherol prevents endothelial dysfunction due to oxidized LDL by inhibiting protein kinase C stimulation | Q37357656 |
| | Cardiomyopathy associated with nonendemic selenium deficiency in a Caucasian adolescent | Q37890873 |
| | Micronutrients: highlights and research challenges from the 1994-5 National Diet and Nutrition Survey of people aged 65 years and over | Q40780166 |
| | Selenium-based antihypertensives. Rationale and potential | Q40829775 |
| | Copper deficiency and heart disease: molecular basis, recent advances and current concepts | Q40871230 |
| | Molecular basis of alpha-tocopherol control of smooth muscle cell proliferation | Q41055602 |
| | Thiamine deficiency in patients with congestive heart failure receiving long-term furosemide therapy: a pilot study | Q41157810 |
| | Exercise limitation in chronic heart failure: central role of the periphery | Q41187847 |
| | Dietary copper: a powerful determinant of cholesterolemia | Q41431509 |
| | Homocysteinemia due to folate deficiency | Q41456055 |
| | Increased cholesterol in plasma in a young man during experimental copper depletion | Q41579395 |
| | Serum Levels of Selenium, Calcium, Copper Magnesium, Manganese and Zinc in Various Human Diseases | Q41690645 |
| | Prognostic importance of the serum magnesium concentration in patients with congestive heart failure | Q41867729 |
| | Diseases of the heart in the works of Hippocrates | Q42015204 |
| | Improved left ventricular function after thiamine supplementation in patients with congestive heart failure receiving long-term furosemide therapy | Q42278890 |
| | Decreased type VI adenylyl cyclase mRNA concentration and Mg(2+)-dependent adenylyl cyclase activities and unchanged type V adenylyl cyclase mRNA concentration and Mn(2+)-dependent adenylyl cyclase activities in the left ventricle of rats with myoca | Q42475796 |
| | Effect of L-carnitine on myocardial metabolism: results of a balanced, placebo-controlled, double-blind study in patients undergoing open heart surgery | Q42542820 |
| | Arterial endothelial barrier dysfunction: actions of homocysteine and the hypoxanthine-xanthine oxidase free radical generating system | Q42714111 |
| | Electrocardiographic Q-Tc prolongation associated with infusion of intravenous pamidronate disodium | Q43240672 |
| | Experimental production of magnesium deficiency in man. | Q43485303 |
| | Improvement of hypocalcemic cardiomyopathy by correction of serum calcium level | Q43682871 |
| | Trends in hospitalization for heart failure in Scotland 1980-1990. | Q44454010 |
| | Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins | Q44610145 |
| | Combined treatment with vitamins E and C in experimental myocardial infarction in pigs | Q44790853 |
| | Plasma homocyst(e)ine, folate, and vitamin B-12 concentrations and risk for early-onset coronary artery disease | Q45153613 |
| | Heart failure in rats causes changes in skeletal muscle morphology and gene expression that are not explained by reduced activity | Q45234714 |
| | Prevalence and hemodynamic correlates of malnutrition in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. | Q46019408 |
| | Effect of zinc deficiency on lipid peroxidation status and infarct size in rat hearts | Q47388582 |
| | Antioxidant vitamin C improves endothelial dysfunction in chronic smokers | Q71884045 |
| | Ventricular fibrillation due to hypocalcemia after parathyroidectomy with autotransplantation of parathyroid tissue in a dialysis patient | Q71898694 |
| | L-Propionylcarnitine Effect on Postexercise and Postischemic Hyperemia in Patients Affected by Peripheral Vascular Disease | Q71969950 |
| | Thiamine deficiency in hospitalized elderly patients | Q72067585 |
| | Nutritional assessment and muscle energy metabolism in severe chronic congestive heart failure—effects of long-term dietary supplementation | Q72113691 |
| | Thiamin status, diuretic medications, and the management of congestive heart failure | Q72168756 |
| | Congestive heart failure caused by vitamin D deficiency? | Q72203174 |
| | Noninvasive evaluation of cardiac hemodynamics during exercise in patients with chronic heart failure: effects of short-term coenzyme Q10 treatment | Q72243091 |
| | Homocysteine and coronary artery disease in French Canadian subjects: relation with vitamins B12, B6, pyridoxal phosphate, and folate | Q72267698 |
| | Increased resting metabolic rate in patients with congestive heart failure | Q72290760 |
| | Vitamin status and intake as primary determinants of homocysteinemia in an elderly population | Q72305071 |
| | Protein-energy malnutrition in patients with ischemic and nonischemic dilated cardiomyopathy and congestive heart failure | Q72423702 |
| | Insulin resistance in chronic heart failure | Q72459346 |
| | Protection from oxidized LDL-induced leukocyte adhesion to microvascular and macrovascular endothelium in vivo by vitamin C but not by vitamin E | Q72571580 |
| | Weak antioxidant defenses make the heart a target for damage in copper-deficient rats | Q72572984 |
| | Comparative aspects of cardiac ultrastructure, morphometry, and electrocardiography of hearts from rats fed restricted dietary copper and selenium | Q72625778 |
| | Ferrylmyoglobin formation induced by acute magnesium deficiency in perfused rat heart causes cardiac failure | Q72705842 |
| | Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population | Q72902080 |
| | Adriamycin-induced early changes in myocardial antioxidant enzymes and their modulation by probucol | Q73108705 |
| | The influence of antioxidant nutrients on platelet function in healthy volunteers | Q73112117 |
| | Elevated plasma levels of tumor necrosis factor in chronic heart failure with cachexia | Q73168496 |
| | Vitamin E supplementation and cardiovascular events in high-risk patients | Q73365511 |
| | Relation of daily activity levels in patients with chronic heart failure to long-term prognosis | Q73370421 |
| | Skeletal muscle alterations in patients with chronic heart failure | Q73415707 |
| | Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia | Q73437882 |
| | Plasma homocysteine levels and mortality in patients with coronary artery disease | Q73520715 |
| | The effect of coenzyme Q10 in patients with congestive heart failure | Q73680260 |
| | Tumor necrosis factor and steroid metabolism in chronic heart failure: possible relation to muscle wasting | Q73746097 |
| | Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure | Q74191308 |
| | alpha-Tocopherol protects against expression of adhesion molecules on neutrophils and endothelial cells | Q74382192 |
| | Homocysteine enhances neutrophil-endothelial interactions in both cultured human cells and rats In vivo | Q74583474 |
| | Loss of bone mineral in patients with cachexia due to chronic heart failure | Q74598339 |
| | Study on propionyl-L-carnitine in chronic heart failure | Q74601680 |
| | THE PATHOGENESIS OF CARDIAC CACHEXIA | Q76857036 |
| | Successes and failures of current treatment of heart failure | Q77296413 |
| | Acute and chronic effects of propionyl-L-carnitine on the hemodynamics, exercise capacity, and hormones in patients with congestive heart failure | Q77452306 |
| | Decrease of cytochrome c oxidase protein in heart mitochondria of copper-deficient rats | Q77671644 |
| | Furosemide and digoxin inhibit thiamine uptake in cardiac cells | Q77676039 |
| | Relation of calcium, vitamin D, and dairy food intake to ischemic heart disease mortality among postmenopausal women | Q77916693 |
| | Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation | Q47671926 |
| | Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities | Q48501090 |
| | Altered contractile properties of rat cardiac muscle during experimental thiamine deficiency and food deprivation | Q48888556 |
| | Vitamin E consumption and the risk of coronary disease in women | Q50126258 |
| | Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study. | Q50909239 |
| | Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis. | Q50954984 |
| | Oxy free radical system in heart failure and therapeutic role of oral vitamin E. | Q50977174 |
| | Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial. | Q51558185 |
| | Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study. | Q51568729 |
| | Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure. | Q51574264 |
| | Effects of L-propionylcarnitine on ischemia-induced myocardial dysfunction in men with angina pectoris. | Q51594528 |
| | Daily energy requirements in heart failure patients. | Q52253750 |
| | Homocysteine redox receptor and regulation of extracellular matrix components in vascular cells. | Q52529329 |
| | Recognising the limits of randomized clinical trials. | Q52904792 |
| | Lack of effect of coenzyme Q on left ventricular function in patients with congestive heart failure. | Q53551020 |
| | Coenzyme Q10 as an adjunctive in the treatment of chronic congestive heart failure. The Q10 Study Group. | Q53646769 |
| | Vitamin C improves endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. | Q54144635 |
| | Lipid peroxidation and susceptibility of low-density lipoprotein to in vitro oxidation in hyperhomocysteinaemia. | Q54178663 |
| | Effects of long-term oral magnesium chloride replacement in congestive heart failure secondary to coronary artery disease. | Q54226163 |
| | Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. | Q55066490 |
| | Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. | Q55067141 |
| | Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. | Q55067566 |
| | Serum Folate and Risk of Fatal Coronary Heart Disease | Q56171251 |
| | Beta-carotene intake and risk of nonfatal acute myocardial infarction in women | Q57561168 |
| | The associations of levels of serum potassium and magnesium with ventricular premature complexes (the Framingham Heart Study) | Q57740695 |
| | Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery Stenosis | Q57746092 |
| | Bone Mass, Vitamin D Deficiency, and Hyperparathyroidism in Congestive Heart Failurefn1fn1This work was supported in part by Grants AR-41391 and RR-006645 from the National Institutes of Health | Q60777494 |
| | Treatment of hypertension with ascorbic acid | Q61704103 |
| | Long-Term Ascorbic Acid Administration Reverses Endothelial Vasomotor Dysfunction in Patients With Coronary Artery Disease | Q61704107 |
| | Lipid peroxidation in homocysteinaemia | Q67560177 |
| | A low plasma selenium is a risk factor for peripartum cardiomyopathy. A comparative study in Sahelian Africa | Q67577432 |
| | Dietary intake and nutritional status in regard to zinc of institutionalized aged | Q67600685 |
| | Ubiquinone (coenzyme Q10) in the long-term treatment of idiopathic dilated cardiomyopathy | Q67602640 |
| | Zinc deficiency, ethanol, and myocardial ischemia affect lipoperoxidation in rats | Q67709879 |
| | Riboflavin deficiency in infants and children with heart disease | Q67763230 |
| | Hypomagnesaemia in elderly digitalised patients | Q67942659 |
| | Plasma endothelin in chronic heart failure | Q68054244 |
| | Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure | Q68084268 |
| | Resting energy expenditure in chronic cardiac failure | Q68242754 |
| | Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene | Q68289613 |
| | Elevated circulating levels of tumor necrosis factor in severe chronic heart failure | Q68524243 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chronic heart failure | Q11829287 |
| | heart failure | Q181754 |
| P304 | page(s) | 1765-1774 | |
| P577 | publication date | 2001-06-01 | |
| P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
| P1476 | title | Chronic heart failure and micronutrients | |
| P478 | volume | 37 | |